(1S,4S)-2-(4-Chlorobenzyl)-2,5-diaza-bicyclo[2.2.1]heptane, 1g

4-(5-Bromo-2-thienyl)-4-oxobutyric acid, 95.0%, 2.5g

4-fluorobicyclo[2.2.2]octan-1-amine hydrochloride, 95.0%, 100mg

3-methyl-1,2,4-thiadiazole-5-carbohydrazide, 95.0%, 250mg

Pointes de pipettes MIKRO 0,1–10 μl avec graduation, Sachet, 1000 pièces, Non stérile, 1000 pièces

(R)-2-((tert-Butoxycarbonyl)amino)-3-(2,6-dichlorophenyl)propanoic acid, 95%, 1g

Methyl (4-oxocyclohexyl)carbamic acid tert-butyl ester, 95.0%, 100g

Ethyl 4-formyl-1H-pyrrole-2-carboxylate, 95.0%, 10g

2-(3-(pyridin-4-yl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)ethan-1-amine, 95.0%, 250mg

4-(Hydroxymethyl)piperidine-4-carbonitrile hydrochloride, 98%, 250mg

2-(4-Ethoxybenzoyl)-4-methylpyridine, 97.0%, 1g

N-(4-Bromophenyl-N-(4-carbethoxyphenyl)amine, 97.0%, 1g

5-Bromo-1-ethyl-1H-indole-2,3-dione, 95.0%, 250mg